» 全て » 株価予想 » Vertex Pharmaceuticals Incorporated Common Stock 予報

Vertex Pharmaceuticals Incorporated Common Stock 予報: 明日, 週, 月, 5年

更新されました: April 22 · 2026 at 07:03 UTC
▼ -0.59%Market Cap $111.09B · Technical analysis Bearish · Focus area Price + volatility

予測の概要

時間枠予想価格過去歴史的洞察力
明日$433.50 -0.71%昨日$437.89 +0.30%Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
$426.99 -2.20%先週$440.62 +0.92%The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
$416.13 -4.69%先月$445.18 +1.97%The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
$399.87 -8.41%去年$452.01 +3.53%The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$361.75 -17.14%5年前$468.02 +7.20%The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
明日$433.50 -0.71%
昨日$437.89 +0.30%
Tomorrow's Vertex Pharmaceuticals Incorporated Common Stock (VRTX) setup is anchored to $436.59 and targets $433.50 (-0.71%). The near-term read is downside; watch $449.69 / $423.49 because daily realized volatility is about 3.65%.
$426.99 -2.20%
先週$440.62 +0.92%
The 7-day Vertex Pharmaceuticals Incorporated Common Stock model moves from $440.62 to $426.99 (-2.20%). It gives downside momentum context for this stock, so breaks around $449.69 / $423.49 matter more than a single tick.
$416.13 -4.69%
先月$445.18 +1.97%
The 1-month Vertex Pharmaceuticals Incorporated Common Stock target is $416.13 (-4.69%), compared with the live reference near $436.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
$399.87 -8.41%
去年$452.01 +3.53%
The 1-year Vertex Pharmaceuticals Incorporated Common Stock scenario points to $399.87 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年$361.75 -17.14%
5年前$468.02 +7.20%
The 5-year Vertex Pharmaceuticals Incorporated Common Stock view is $361.75 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

価格表

歴史的予報強気弱気
$446.55$439.51$432.47$425.42$418.381W AgoNow7D F

テクニカル分析

売る中性買う
Bearish
0
強気
3
中性
2
弱気

主要な指標

インジケータ価値信号
Price$436.59 Mid
Daily Change-0.59% Below
Volatility Cap20.0% Mid
Confidence58% Below
Data Sourcenasdaq-screener Mid

過去のデータ

Current$436.59
Daily Change-0.59%
Market Cap$111.09B
Sourcenasdaq-screener
Current$436.59Daily Change-0.59%
Market Cap$111.09BSourcenasdaq-screener

サポートとレジスタンスのレベル

$423.49Support 1
$436.59現在
$449.69Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

価格マイルストーン

主要なレベルと歴史的背景
Current$436.59Live reference price
Used as the anchor for generated forecast calculations.
Next Month$416.13Model projection-4.69%
Directional scenario based on capped drift.

予測精度

私たちのモデルのパフォーマンス
58%
指向性
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
当社のアルゴリズムは、最新の価格動向、ボラティリティ体制、指標シグナルを使用して毎週再調整されます。精度は時間枠によって異なります。短期的な勢いは長期的な予測よりも信頼性が高くなります。
Short term
58%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

投資シナリオ

今日 $1,000 を VRTX に投資した場合
Bullish Scenario
$458.42
+5.00% from current
目標価格$458.42
シナリオUpside momentum
確率50%
Base Scenario
$416.13
-4.69%
目標価格$416.13
シナリオCapped drift
確率58%
Bearish Scenario
$414.76
-5.00% from current
目標価格$414.76
シナリオVolatility drawdown
確率42%
基礎: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

予測要因

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bearish · 40/100
24H drift-0.71%
7D drift-2.20%
30D drift-4.69%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-Off Caution · 35/100
1M outlook-4.69%
1Y outlook-8.41%
5Y outlook-17.14%

よくある質問

Q What is the Vertex Pharmaceuticals Incorporated Common Stock (VRTX) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Vertex Pharmaceuticals Incorporated Common Stock is projected near $433.50 versus the current reference around $436.59. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for VRTX?
The weekly Vertex Pharmaceuticals Incorporated Common Stock model points to $426.99, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Vertex Pharmaceuticals Incorporated Common Stock 1-month and 1-year targets?
The Vertex Pharmaceuticals Incorporated Common Stock 1-month target is $416.13 (-4.69%), while the 1-year target is $399.87 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Vertex Pharmaceuticals Incorporated Common Stock 5-year scenario differ from short-term rows?
The Vertex Pharmaceuticals Incorporated Common Stock long-horizon scenario sits near $361.75 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are VRTX support and resistance zones right now?
For Vertex Pharmaceuticals Incorporated Common Stock, nearest resistance is around $423.49, while nearest support is around $449.69. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Vertex Pharmaceuticals Incorporated Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.